18 results
10-Q
2023 Q3
EX-3.1
SPRO
Spero Therapeutics Inc
Quarterly report
13 Nov 23
4:02pm
8-K/A
EX-3.1
SPRO
Spero Therapeutics Inc
16 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-3.1
SPRO
Spero Therapeutics Inc
10 Oct 23
Departure of Directors or Certain Officers
8:28am
8-K
EX-3.1
SPRO
Spero Therapeutics Inc
18 Aug 21
Departure of Directors or Certain Officers
4:48pm
8-K
EX-3.1
SPRO
Spero Therapeutics Inc
14 Sep 20
Entry into a Material Definitive Agreement
9:26am
8-K
EX-3.1
iwksimqwh7
28 Feb 20
Material Modifications to Rights of Security Holders
4:31pm
8-K
EX-3.1
ljrv u810yudgiaryr
16 Nov 18
Entry into a Material Definitive Agreement
9:01am
8-K
EX-3.1
53z400
17 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
EX-3.2
vrx9e
6 Nov 17
Spero Therapeutics Announces Closing of Initial Public Offering
12:00am
8-K
EX-3.1
s753pgxyofnnenseo 67
6 Nov 17
Spero Therapeutics Announces Closing of Initial Public Offering
12:00am
S-1/A
EX-3.5
zyvu519j 9n
23 Oct 17
IPO registration (amended)
12:00am
S-1/A
EX-3.3
908zc8qpa7uf8a jbp
23 Oct 17
IPO registration (amended)
12:00am
S-1/A
EX-3.2
m2oi8 0bhfy
23 Oct 17
IPO registration (amended)
12:00am
S-1
EX-3.4
hn77cnhryo jwn
6 Oct 17
IPO registration
12:00am
S-1
EX-3.1
8ue0x8a7pp4ol v2
6 Oct 17
IPO registration
12:00am
DRS
EX-3
g7e g3pobh2zxlk3yw
25 Aug 17
Draft registration statement
12:00am
DRS
EX-3
0a8kx2
25 Aug 17
Draft registration statement
12:00am
- Prev
- 1
- Next